RT Journal Article
SR Electronic
T1 Replicating extensive brain structural heterogeneity in individuals with schizophrenia and bipolar disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.08.20095091
DO 10.1101/2020.05.08.20095091
A1 Wolfers, Thomas
A1 Rokicki, Jaroslav
A1 Alnæs, Dag
A1 Berthet, Pierre
A1 Agartz, Ingrid
A1 Kia, Seyed Mostafa
A1 Kaufmann, Tobias
A1 Zabihi, Mariam
A1 Moberget, Torgeir
A1 Melle, Ingrid
A1 Beckmann, Christian F
A1 Andreassen, Ole A
A1 Marquand, Andre F
A1 Westlye, Lars T
YR 2021
UL http://medrxiv.org/content/early/2021/01/24/2020.05.08.20095091.abstract
AB Identifying brain processes involved in the risk and development of mental disorders is a major aim. We recently reported substantial inter-individual heterogeneity in brain structural aberrations among patients with schizophrenia and bipolar disorder. Estimating the normative range of voxel-based morphometry (VBM) data among healthy individuals using a gaussian process regression (GPR) enables us to map individual deviations from the healthy range in unseen datasets. Here we aim to replicate our previous results in two independent samples of patients with schizophrenia (n1=94; n2=105), bipolar disorder (n1=116; n2=61) and healthy individuals (n1=400; n2=312). In line with previous findings with exception of the cerebellum our results revealed robust group level differences between patients and healthy individuals, yet only a small proportion of patients with schizophrenia or bipolar disorder exhibited extreme negative deviations from normality in the same brain regions. These direct replications support that group level-differences in brain structure disguise considerable individual differences in brain aberrations, with important implications for the interpretation and generalization of group-level brain imaging findings to the individual with a mental disorder.Competing Interest StatementO.A.A. is a consultant to HealthLytix and received speakers honorarium from Lundbeck. C.B. is shareholder of and director of SBG Neuro. The other authors declare that they have no competing interests.Funding StatementThe study is supported by the Research Council of Norway (223273, 249795, 298646, 300768, 276082), the South-Eastern Norway Regional Health Authority (2014097, 2015073, 2016083, 2019101), a Wellcome Trust Innovator award (BRAINCHART, 215698/Z/19/Z), and the European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG Grant 802998 and Grant 847776). This work was performed on the TSD (Tjenester for Sensitive Data) facilities, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo, IT-Department (USIT) with resources provided by UNINETT Sigma2 - the National Infrastructure for High Performance Computing and Data Storage in Norway. TW gratefully acknowledges the Niels Stensen Fellowship for supporting this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Regional Committee for Medical Research Ethics and the Norwegian Data InspectorateAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAs the data is clinical data including patient information access is restricted in accordance with European and Norwegian law.